This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auparakkitanon, S.
Right arrow Articles by Wilairat, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auparakkitanon, S.
Right arrow Articles by Wilairat, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2006, p. 2197-2200, Vol. 50, No. 6
0066-4804/06/$08.00+0     doi:10.1128/AAC.00119-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Targeting of Hematin by the Antimalarial Pyronaridine

Saranya Auparakkitanon,1* Soebsakul Chapoomram,2 Kannika Kuaha,3 Thamrong Chirachariyavej,1 and Prapon Wilairat2

Division of Toxicology, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital,1 Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand,2 Department of Immunology, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand3

Received 28 January 2006/ Returned for modification 7 March 2006/ Accepted 21 March 2006

Pyronaridine, 2-methoxy-7-chloro-10[3',5'-bis(pyrrolidinyl-1-methyl-)4'hydroxyphenyl]aminobenzyl-(b)-1,5-naphthyridine, a new Mannich base schizontocide originally developed in China and structurally related to the aminoacridine drug quinacrine, is currently undergoing clinical testing. We now show that pyronaridine targets hematin, as demonstrated by its ability to inhibit in vitro ß-hematin formation (at a concentration equal to that of chloroquine), to form a complex with hematin with a stoichiometry of 1:2, to enhance hematin-induced red blood cell lysis (but at 1/100 of the chloroquine concentration), and to inhibit glutathione-dependent degradation of hematin. Our observations that pyronaridine exerted this mechanism of action in situ, based on growth studies of Plasmodium falciparum K1 in culture showing antagonism of pyronaridine in combination with antimalarials (chloroquine, mefloquine, and quinine) that inhibit ß-hematin formation, were equivocal.

* Corresponding author. Mailing address: Division of Toxicology, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. Phone: (662) 201-1354. Fax: (662) 201-1338. E-mail: rasao{at}mahidol.ac.th.

Antimicrobial Agents and Chemotherapy, June 2006, p. 2197-2200, Vol. 50, No. 6
0066-4804/06/$08.00+0     doi:10.1128/AAC.00119-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Biagini, G. A., Fisher, N., Berry, N., Stocks, P. A., Meunier, B., Williams, D. P., Bonar-Law, R., Bray, P. G., Owen, A., O'Neill, P. M., Ward, S. A. (2008). Acridinediones: Selective and Potent Inhibitors of the Malaria Parasite Mitochondrial bc1 Complex. Mol. Pharmacol. 73: 1347-1355 [Abstract] [Full Text]  
  • Huy, N. T., Mizunuma, K., Kaur, K., Nhien, N. T. T., Jain, M., Uyen, D. T., Harada, S., Jain, R., Kamei, K. (2007). 2-tert-Butyl-8-Quinolinamines Exhibit Potent Blood Schizontocidal Antimalarial Activity via Inhibition of Heme Crystallization. Antimicrob. Agents Chemother. 51: 2842-2847 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»